Literature DB >> 10025441

Heritability estimates for psychotic disorders: the Maudsley twin psychosis series.

A G Cardno1, E J Marshall, B Coid, A M Macdonald, T R Ribchester, N J Davies, P Venturi, L A Jones, S W Lewis, P C Sham, I I Gottesman, A E Farmer, P McGuffin, A M Reveley, R M Murray.   

Abstract

BACKGROUND: Previous twin studies have supported a genetic contribution to the major categories of psychotic disorders, but few of these have employed operational diagnostic criteria, and no such study has been based on a sample that included the full range of functional psychotic disorders.
METHODS: A total of 224 twin probands (106 monozygotic, 118 dizygotic) with a same-sex co-twin and a lifetime history of psychosis was ascertained from the service-based Maudsley Twin Register in London, England. Research Diagnostic Criteria psychotic diagnoses were made on a lifetime-ever basis. Main-lifetime diagnoses of DSM-III-R and International Statistical Classification of Diseases, 10th Revision schizophrenia were also made. Probandwise concordance rates and correlations in liability were calculated, and biometrical model fitting applied.
RESULTS: A substantial genetic contribution to variance in liability was confirmed for the major diagnostic categories except Research Diagnostic Criteria depressive psychosis and unspecified functional psychosis, where familial transmission was confirmed, but the relative contribution of genetic and common environmental factors was unclear. Heritability estimates for Research Diagnostic Criteria schizophrenia, schizoaffective disorder, mania, DSM-III-R schizophrenia, and International Statistical Classification of Diseases, 10th Revision schizophrenia were all between 82% and 85%. None of the estimates differed significantly from any other.
CONCLUSIONS: Heritability estimates for schizophrenia, schizoaffective disorder, and mania were substantial and similar. Population morbid risk estimates were inferred rather than directly measured, but the results were very similar to those from studies where morbid risks were directly estimated.

Entities:  

Mesh:

Year:  1999        PMID: 10025441     DOI: 10.1001/archpsyc.56.2.162

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  191 in total

Review 1.  Genetic insights into schizophrenia.

Authors:  A S Bassett; E W Chow; D M Waterworth; L Brzustowicz
Journal:  Can J Psychiatry       Date:  2001-03       Impact factor: 4.356

Review 2.  Science, medicine, and the future. Behaviour and genes.

Authors:  P McGuffin; N Martin
Journal:  BMJ       Date:  1999-07-03

3.  Prefrontal and striatal volumes in monozygotic twins concordant and discordant for schizophrenia.

Authors:  Ulrich Ettinger; Anne Schmechtig; Timothea Toulopoulou; Charmaine Borg; Claire Orrells; Sheena Owens; Kazunori Matsumoto; Neeltje E van Haren; Mei-Hua Hall; Veena Kumari; Philip K McGuire; Robin M Murray; Marco Picchioni
Journal:  Schizophr Bull       Date:  2010-06-10       Impact factor: 9.306

Review 4.  Cell biology of the BLOC-1 complex subunit dysbindin, a schizophrenia susceptibility gene.

Authors:  Ariana P Mullin; Avanti Gokhale; Jennifer Larimore; Victor Faundez
Journal:  Mol Neurobiol       Date:  2011-04-26       Impact factor: 5.590

5.  Metaphors in behavioral genetics.

Authors:  A Nordgren
Journal:  Theor Med Bioeth       Date:  2003

Review 6.  Linkage studies of schizophrenia.

Authors:  Brien Riley
Journal:  Neurotox Res       Date:  2004       Impact factor: 3.911

7.  Positive association between NTNG1 and schizophrenia in Chinese Han population.

Authors:  Yuzhang Zhu; Huan Yang; Yuxia Bi; Ying Zhang; Chao Zhen; Shoufu Xie; Heping Qin; Jia He; Li Liu; Ying Liu
Journal:  J Genet       Date:  2011-12       Impact factor: 1.166

8.  Examining the independent and joint effects of molecular genetic liability and environmental exposures in schizophrenia: results from the EUGEI study.

Authors:  Sinan Guloksuz; Lotta-Katrin Pries; Philippe Delespaul; Gunter Kenis; Jurjen J Luykx; Bochao D Lin; Alexander L Richards; Berna Akdede; Tolga Binbay; Vesile Altınyazar; Berna Yalınçetin; Güvem Gümüş-Akay; Burçin Cihan; Haldun Soygür; Halis Ulaş; EylemŞahin Cankurtaran; Semra Ulusoy Kaymak; Marina M Mihaljevic; Sanja Andric Petrovic; Tijana Mirjanic; Miguel Bernardo; Bibiana Cabrera; Julio Bobes; Pilar A Saiz; María Paz García-Portilla; Julio Sanjuan; Eduardo J Aguilar; José Luis Santos; Estela Jiménez-López; Manuel Arrojo; Angel Carracedo; Gonzalo López; Javier González-Peñas; Mara Parellada; Nadja P Maric; Cem Atbaşog Lu; Alp Ucok; Köksal Alptekin; Meram Can Saka; Celso Arango; Michael O'Donovan; Bart P F Rutten; Jim van Os
Journal:  World Psychiatry       Date:  2019-06       Impact factor: 49.548

Review 9.  The emerging molecular architecture of schizophrenia, polygenic risk scores and the clinical implications for GxE research.

Authors:  Conrad Iyegbe; Desmond Campbell; Amy Butler; Olesya Ajnakina; Pak Sham
Journal:  Soc Psychiatry Psychiatr Epidemiol       Date:  2014-01-17       Impact factor: 4.328

10.  Grey matter, an endophenotype for schizophrenia? A voxel-based morphometry study in siblings of patients with schizophrenia.

Authors:  Jorien van der Velde; Paula M Gromann; Marte Swart; Lieuwe de Haan; Durk Wiersma; Richard Bruggeman; Lydia Krabbendam; André Aleman
Journal:  J Psychiatry Neurosci       Date:  2015-05       Impact factor: 6.186

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.